Furthermore, Stat3 is widely expressed in breast cancer and orally bioavailable small-molecule inhibitor of Stat3 can regress human breast cancer xenografts [12], suggesting that Stat3 is a potential therapeutic target for breast cancer. The gene discussed is STAT3; the disease is breast carcinoma.